calendar
13,623 catalysts · 3,603 8k filing · 2,401 grant · 2,100 approval · 1,445 device 510k · 1,074 device recall · 1,000 device adverse event
13,623 catalysts · 3,603 8k filing · 2,401 grant · 2,100 approval · 1,445 device 510k · 1,074 device recall · 1,000 device adverse event
Sponsor: RHODES PHARMS. Form: TABLET. Route: SUBLINGUAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: MYLAN TECHNOLOGIES. Form: FILM, EXTENDED RELEASE. Route: TRANSDERMAL
Sponsor: ACTAVIS LABS UT INC. Form: CAPSULE. Route: ORAL
Sponsor: HOSPIRA. Form: INJECTABLE. Route: INJECTION
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: ANI PHARMS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL
Sponsor: ETHYPHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: AMNEAL PHARMS. Form: SYRUP. Route: ORAL
Sponsor: PFIZER. Form: INJECTABLE. Route: INJECTION
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: SPECGX LLC. Form: SOLUTION. Route: ORAL
Sponsor: SPECGX LLC. Form: SOLUTION. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: STRIDES PHARMA INTL. Form: TABLET. Route: ORAL
Sponsor: TRIS PHARMA INC. Form: TABLET. Route: ORAL
Sponsor: TRIS PHARMA INC. Form: TABLET. Route: ORAL
Sponsor: ABHAI LLC. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL. Form: TABLET. Route: ORAL
Sponsor: BARR LABS INC. Form: TABLET. Route: ORAL
Sponsor: OSMOTICA PHARM US. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: ABHAI LLC. Form: TABLET. Route: ORAL
Sponsor: ASCENT PHARMS INC. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: PURDUE PHARMA LP. Form: TABLET, EXTENDED RELEASE. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SYRUP. Route: ORAL
Sponsor: GENUS LIFESCIENCES. Form: SYRUP. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: LANNETT CO INC. Form: TABLET. Route: ORAL
Sponsor: BARR. Form: TABLET. Route: ORAL
Sponsor: REACX PHARMS. Form: IMPLANT. Route: IMPLANTATION
Sponsor: ROSEMONT. Form: SOLUTION. Route: ORAL
Sponsor: STRIDES PHARMA. Form: TABLET. Route: ORAL
Sponsor: FOSUN PHARMA. Form: TABLET. Route: ORAL
Sponsor: CHARTWELL RX. Form: SOLUTION. Route: ORAL
Sponsor: FOSUN PHARMA. Form: TABLET. Route: ORAL
Sponsor: ALKERMES. Form: FOR SUSPENSION, EXTENDED RELEASE. Route: INTRAMUSCULAR
Sponsor: QUAGEN. Form: SOLUTION. Route: ORAL
Sponsor: FRESENIUS KABI USA. Form: INJECTABLE. Route: INJECTION
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: HIKMA. Form: SOLUTION. Route: ORAL
Sponsor: ENDO OPERATIONS. Form: TABLET. Route: ORAL
Sponsor: SUN PHARM. Form: TABLET. Route: SUBLINGUAL
Sponsor: HIKMA. Form: SYRUP. Route: ORAL